Compare SLND & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLND | SGMO |
|---|---|---|
| Founded | 1900 | 1995 |
| Country | United States | United States |
| Employees | 2100 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.6M | 141.2M |
| IPO Year | N/A | 2000 |
| Metric | SLND | SGMO |
|---|---|---|
| Price | $0.93 | $0.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.00 | ★ $5.75 |
| AVG Volume (30 Days) | 99.2K | ★ 4.1M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,567,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $0.95 | $0.35 |
| 52 Week High | $5.34 | $1.05 |
| Indicator | SLND | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 17.49 | 50.46 |
| Support Level | N/A | $0.36 |
| Resistance Level | $4.72 | $0.56 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 6.18 | 29.03 |
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.